Literature DB >> 2559031

Inhibition by halothane, but not by isoflurane, of oxidative response to opsonized zymosan in whole blood.

C Lieners1, H Redl, G Schlag, D E Hammerschmidt.   

Abstract

In an attempt to clarify some apparent discrepancies in reports of the effects of anesthetic agents upon granulocyte function, we studied the effects of halothane and isoflurane, using techniques that allowed us to perform the assays in and in sealed vials to prevent volatile gas evolution: assay gas concentrations were measured, rather than inferred. Chemiluminescence, superoxide production, and hydrogen peroxide production were assessed after presentation of opsonized zymosan as a phagocytic stimulus. Incubation with halothane led to a highly statistically significant dose-related inhibition of chemiluminescence (maximum 66%), H2O2 production (67%) and .O2- production (61%), within the concentration range observed in blood from patients undergoing general anesthesia. In contrast, the presence of isoflurane led to no statistically significant changes in any of the functions measured. Cells harvested from patients undergoing elective halothane anesthesia showed the same functional inhibition, but for quantitative differences likely due to the inability to control for dilution effects in clinical samples. It has been suggested that halothane anesthesia may be associated with excess mortality in septic patients; although the results we report are readily reversible, their presence during a prolonged anesthesia could be harmful in a patient who is not immunologically normal and/or who is already infected. Careful clinical trials will be necessary to determine if isoflurane is a superior agent in this context.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559031     DOI: 10.1007/BF00914306

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Postsurgical granulocyte dysfunction: studies in healthy kidney donors.

Authors:  T K Bowers; J O'Flaherty; R L Simmons; H S Jacob
Journal:  J Lab Clin Med       Date:  1977-10

Review 2.  Update on anaesthesia and the immune response.

Authors:  G C Moudgil
Journal:  Can Anaesth Soc J       Date:  1986-05

3.  The effect of surgery and anesthetic agents on granulocyte-chemiluminescence in whole blood.

Authors:  M Heberer; A M Zbinden; M Ernst; M Dürig; F Harder
Journal:  Experientia       Date:  1985-03-15

4.  Effect of general anesthetics on human granulocyte chemiluminescence.

Authors:  S Lippa; P De Sole; E Meucci; G P Littarru; G De Francisci; S I Magalini
Journal:  Experientia       Date:  1983-12-15

5.  Hematocrit and the solubility of volatile anesthetics in blood.

Authors:  J Lerman; G A Gregory; E I Eger
Journal:  Anesth Analg       Date:  1984-10       Impact factor: 5.108

6.  Effect of enflurane, isoflurane, and nitrous oxide on the microbicidal activity of human polymorphonuclear leukocytes.

Authors:  W D Welch
Journal:  Anesthesiology       Date:  1984-08       Impact factor: 7.892

7.  Phagocytosis during general anesthesia in man.

Authors:  B F Cullen; R B Hume; P B Chretien
Journal:  Anesth Analg       Date:  1975 Jul-Aug       Impact factor: 5.108

8.  Inhibition, by anaesthetic agents, of human leucocyte locomotion towards chemical attractants.

Authors:  G C Moudgil; R B Allan; R J Russell; P C Wilkinson
Journal:  Br J Anaesth       Date:  1977-02       Impact factor: 9.166

9.  Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique.

Authors:  H Redl; D E Hammerschmidt; G Schlag
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

10.  Halothane reversibly inhibits human neutrophil bacterial killing.

Authors:  W D Welch
Journal:  Anesthesiology       Date:  1981-12       Impact factor: 7.892

View more
  1 in total

1.  The effect of the anaesthetic agent isoflurane on the rate of neutrophil apoptosis in vitro.

Authors:  R Tyther; N Fanning; M Halligan; J Wang; H P Redmond; G Shorten
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.